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Abstract 
The purpose of this study was to describe private insurance reimbursements for newborn hearing screening (NBHS) in 
the United States. Data from the MarketScan® Commercial Databases were used to estimate itemized reimbursements 
for privately insured infants born between January 1, 2013–December 31, 2014. Estimates were based on billed claims 
for hearing screening services during infancy among 456,407 infants with birth hospitalization claims (71,820 infants with 
inpatient NBHS and 1,104 infants with outpatient NBHS). The median reimbursement for NBHS was almost three times 
greater when performed in an inpatient setting than outpatient setting. Median reimbursement for NBHS performed in a 
hospital and billed as inpatient service was $148.00 (interquartile range [IQR] $99.52–$210.00) and $57.53 (IQR $34.40–
$120.91) when billed as an outpatient service. The mean reimbursement for NBHS performed in an outpatient hospital 
setting was $136.48 (IQR $86.08–$220.15) and $41.60 (IQR $28.15–$57.52) for NBHS billed in conjunction with an 
office visit (e.g., performed in an audiology clinic, an audiologist’s office, or physician’s office during a routine check-up). 
No NBHS claims were filed for 84.3% of infants (384,587‬/456,407), as NBHS is generally included as a covered service 
bundled along with delivery and newborn care.
Acronyms: ABR = auditory brainstem response; CPT = current procedural terminology, ICD-9-CM = International 
Classification of Diseases, Ninth Revision, Clinical Modification; IQR = interquartile range; NBHS = newborn hearing 
screening; OAE = otoacoustic emissions
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Almost all infants in the United States are screened soon 
after birth for hearing loss using automated auditory 
brainstem response (automated ABR) and/or otoacoustic 
emissions (OAE). Both OAE and automated ABR tests 
provide non-invasive recordings of physiologic activity 
underlying normal auditory function for the purpose of 
confirming the presence or absence of a hearing loss 
(Wroblewska-Seniuk, Dabrowski, Szyfter, & Mazela, 
2017). These reliable and objective methods of testing 
and screening can be easily performed in newborns and 
infants, either used alone or in sequence (Joint Committee 
on Infant Health [JCIH], 2007; Wroblewska-Seniuk et al., 
2017). 
Little is known about the healthcare cost of newborn 
hearing screening in the United States. Estimates of the 
resource cost of hospital-based NBHS in terms of staff 
time, instruments, and consumables in U.S. hospitals 
published between 1995 and 2002 ranged from $25 to 
$50 per infant screened, adjusted for inflation to 2016 
U.S. dollars, but more current estimates are lacking 
(Grosse, Mason, Gaffney, Thomson, & White, 2018). In 
any case, there may be little relation between resource 
costs, charges, and reimbursements for hospital services. 
When NBHS is conducted by hospital staff, there is usually 
no separate bill and it is bundled in the overall labor 
and delivery charge (Winston-Gerson & Rousch, 2016). 
Some hospitals outsource hearing screening services to 
a contractor, who can bill families and insurers separately. 
Based on anecdotal parent reports, Winston-Gerson and 
Rousch (2016) reported a typical charge for NBHS by a 
contractor is $250 and could be in excess of $500.
An analysis of 2004 insurance claims data reported the 
average private-sector payer cost of screening for hearing 
loss in the hospital was $84 (95% confidence interval 
[CI]: $0–$200) when billed and paid separately from the 
labor and delivery charge (Grosse, 2006). McManus 
et al. (2010) reported proprietary estimates of typical 
direct provider payments by an employer health plan in 
2005 was $82.01 for an OAE test with limited evaluation 
(current procedural terminology [CPT] code 92587) for 
the sole purpose of confirming the presence or absence 
of a hearing loss (McManus et al., 2010). The authors 
of that study did not include the other OAE screening 
CPT code (92558) in their estimates. The purpose of this 
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analysis was to provide more up-to-date information on 
reimbursement rates for privately insured infants who are 
individually billed for NBHS during infancy in both inpatient 
and outpatient settings.
Method
Data Source
This retrospective analysis used claims data from the 
IBM® MarketScan® Commercial Research Databases 
from 2013 through 2015. The commercial databases 
include employer-sponsored insurance claims data for 
approximately 30 to 40 million employees and their 
beneficiaries each year from all U.S. states. The databases 
contain fully integrated, de-identified, individual-level 
data across the entire continuum of care (e.g., inpatient, 
outpatient, outpatient pharmacy, laboratory) that capture 
real-world treatment patterns and expenditures (Truven 
Health Analytics, 2017). Each enrollee is assigned a de-
identified unique number, allowing linkage across claims 
over time. MarketScan data is de-identified and their 
analysis is not classified by the Centers for Disease Control 
and Prevention as human subjects research and has been 
determined not to require an Institutional Review Board. 
Claims were identified using the International Classification 
of Diseases, Ninth Revision, Clinical Modification (ICD-
9-CM) codes (Table 1). Inpatient and outpatient data 
were extracted from MarketScan Research Databases 
(2013–2015) for infants born between January 1, 2013 
and December 31, 2014, who were individually billed 
for NBHS, did not die during the study period, and had 
a first claim with a delivery code. The analysis included 
the following information: birth year, gender of patient 
(male/female), setting (inpatient/outpatient), outpatient 
place of service, census division, diagnoses, procedures, 
service date, procedure age (days), net payment, and 
health plan type. An algorithm (Figure 1 and Table 1) was 
used to create a proxy birth date using the admission 
date of the first inpatient claim for the baby containing a 
delivery code (ICD-9-CM: V30-31, V33-V34, V36-V37, 
and V39). We analyzed three CPT codes typically used 
for hearing screening (American Academy of Pediatrics, 
2016): 92586 (automated ABR), 92558 (screening OAE), 
and 92587 (distortion product evoked OAE or OAE with 
limited evaluation). See Table 1 for detailed descriptions. 
OAE comprehensive diagnostic evaluation code 92588, 
used to bill for a test to determine the amplitude level of 
an otoacoustic emission output at each discrete frequency 
and not to determine the presence or absence of a hearing 
loss, was not examined. Service date was the date when 
the procedure or service occurred. 
Table 1
List of Newborn Birth and Hearing Screening Codes
Code(s) Code Description
Newborn ICD-9-CM 
Delivery Codes
V30-31, V33-V34, 
V36-V37, V39
Live birth
Newborn Hearing 
Screening CPT Codes
92586 Automated ABR
Auditory evoked potentials for 
evoked response audiometry 
and/or testing of the central 
nervous system; limited
92558 Screening OAE
Evoked otoacoustic emissions, 
screening; qualitative 
measurement of distortion 
product or transient evoked 
otoacoustic emissions, 
automated analysis
92587 OAE Limited 
Evaluation
Distortion product evoked 
otoacoustic emissions; limited 
evaluation (to confirm the 
presence or absence of hearing 
disorder, 3–6 frequencies) or 
transient evoked otoacoustic 
emissions, with interpretation 
and report
Note. ABR = automated auditory brainstem response; CPT = 
current procedural terminology codes; ICD-9-CM = International 
Classification of Diseases, 9th Revision, Clinical Modification; 
OAE = otoacoustic emissions.
Figure 1. Flowchart depicting the selection process of 
inpatient (left) and outpatient claims (right) included in the 
present study. CPT = current procedural terminology.
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*Billing codes for newborn hearing screening (NBHS) include 
Current Procedures Terminology codes: 92558, 92586, and 92587. 
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Table 2 
Descriptive Summary of Individually Billed Newborn 
Hearing Screening Claims for Infants Born 2013–2014
Variable
Newborn Hearing Screening
Inpatient Outpatient
n (%) n (%)
Total Claims 72,146 1,300
Total Enrollees 71,820 1,104
Mean number of 
Claims (Range) 1.0 (1.0–1.0) 1.2 (1.0–4.0)
Net Payment 
Reimbursements
Mean Net Payment 
(Range)
$159.46
($1.04–$1580.10)
$96.89
($2.03–$1320.78)
Median Net 
Payment (IQR)
$148.00
($99.52–$210.00)
$57.53
($34.40–$120.91)
Mean Net Payment 
for Outpatient Place 
of Service (Range)
Office N/A $50.68($4.11–$714.00)
Outpatient Hospital N/A $169.87($2.03–$1320.78)
Median Net Payment 
for Outpatient Place 
of Service (IQR)
Office N/A $41.60($28.15–$57.52)
Outpatient Hospital N/A $136.48($86.08–$220.15)
Gender of Patient
Male 37,403 (52.1) 608 (55.1)
Female 34,417 (47.9) 496 (44.9)
Note. IQR = Interquartile Range.
Procedure age (days) was estimated using the difference 
between service date and proxy birth date. Net payment is 
defined as the payment received by the provider, excluding 
patient out-of-pocket and coordination of benefits. Claims 
were categorized as inpatient or outpatient using the place 
of service code. For inpatient claims, the place of service 
codes included inpatient hospital, hospital emergency 
room, and birthing center. Inpatient claims represent billing 
as occurring in the hospital inpatient setting when a patient 
was admitted into the hospital and a service was provided 
during the hospital stay. The outpatient place of service 
codes included outpatient hospital and office. Outpatient 
services can occur after an infant has been discharged 
from a hospital or birthing center. In the case of NBHS, 
the outpatient service can be a repeat or an initial screen. 
When place of service is coded as an office visit, the 
service can occur in an audiology clinic, an audiologist’s 
office, or a physician’s office during a routine well child 
visit. When the place of service is coded as outpatient 
hospital, the infant is receiving the service as an outpatient 
at a hospital-owned facility. Claims were categorized as 
nine census divisions defined by the U.S. Census Bureau 
(New England, Middle and South Atlantic, East and West 
North Central, East and West South Central, Mountain, 
and Pacific), and unknown region. 
Data Analysis
In this descriptive analysis, all claims for services that an 
individual received on a given service date are assumed 
to refer to a single encounter. The proxy birth date was 
used to limit claims to the first year of life (infancy), that is, 
difference in days between service date and birth date (< 
365 days). Mean, median, range, and interquartile range 
(IQR) of the net payments were calculated by summing 
each claim. Medical expenditures were adjusted for 
inflation to 2014 dollars and reported by care setting and 
place of service.
Claims were excluded if (a) enrollment ID was missing; (b) 
the infant died before discharge; (c) the difference between 
the service date and proxy birth date was a negative 
number (i.e., screening occurred before proxy birth date in 
which proxy birth date could not be determined); (d) infant 
was not individually billed for NBHS or place of service 
was unspecified; and (e) sum of the net payment for a 
single encounter was equal to or less than $1 irrespective 
if the claim was denied or reimbursed. Claims presumed to 
be duplicates of the initial claim were also excluded (claims 
with similar dates and billing codes). Inpatient claims 
were limited to those occurring during birth hospitalization 
(containing both NBHS and delivery codes). All analyses 
were conducted using SAS software version 9.4 (SAS 
Institute Inc., Cary, NC). Descriptive statistics (frequency 
counts and percentages) were used to compare mean 
and median reimbursement rates and IQRs by setting 
(inpatient/outpatient), outpatient place of service, and 
census division.
Results
Among 456,407 privately insured infants born during 
2013–2014, 71,820 (15.7%) had inpatient claims 
for NBHS. Of those infants, 1,104 (1.5%) also had 
outpatient claims for NBHS (Table 2 and Figure 1). 
Mean reimbursement rates for NBHS were higher than 
the median reimbursement rates (Table 2). Median 
reimbursement for NBHS (IQR) performed in a hospital 
setting was $148.00 ($99.52–$210.00) billed as an 
inpatient service, and $57.53 ($34.40–$120.91) billed 
as an outpatient service. The median reimbursement 
for NBHS (IQR) was $136.48 ($86.08–$220.15) for an 
outpatient service in a hospital facility and $41.60 ($28.15–
$57.52) for NBHS billed in conjunction with an office visit 
(Table 2). 
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Reimbursement rates for NBHS varied significantly by 
procedure and setting (Table 3). For inpatient NBHS 
and outpatient office visit NBHS, mean and median 
reimbursements for automated ABR (CPT 92586) were 
substantially higher than OAE hearing screening (CPT 
92558 or 92587). The same was true for outpatient 
hospital-based claims, with reimbursements for automated 
ABR (CPT 92586) slightly higher than for OAE hearing 
screening (CPT 92558 or 92587). About half of the 
inpatient claims for NBHS (49.4%, 249/504) were for 
automated ABR. Most of outpatient claims for NBHS 
(94.2%, 750/796) were for OAE hearing screening 
services. The median reimbursement (IQR) for automated 
ABR was $150.00 ($104.40–$210.68) when billed as an 
inpatient screen, $102.18 ($75.81–$169.13) as an office 
hearing screen, and $164.34 ($94.02–$254.00) as an 
outpatient hospital screen. The median reimbursement 
(IQR) for screening OAE tests (CPT 92558) or OAE with 
limited evaluation (CPT 92587) was $57.80 ($29.37–
$108.68) when billed as an inpatient service, $39.74 
($27.63–$52.54) as an office screening service, and 
$116.90 ($78.22–$178.27) as a hospital outpatient service.
In the outpatient setting, reimbursement rates were higher 
for OAE hearing screening (CPT 92558 or 92587) and 
automated ABR (CPT 92586) occurring as an outpatient 
hospital visit than an office visit, where hearing screens 
were performed in an audiology clinic, an audiologist’s 
office, or a physician’s office (Table 3). Irrespective of 
outpatient place of service, reimbursement for automated 
ABR (CPT 92586) was higher than OAE hearing screening 
(CPT 92558 or 92587).
Table 3
Unweighted Inpatient and Outpatient Hearing Screening Reimbursement Rates* for Newborns Born between 2013 and 2014
Inpatient Hearing Screen (n = 72,176 claims)  
CPT Codes n (%) Mean (Range) Median (IQR)
92558 or 92587 OAE 2,228 (3.1) $73.38 ($2.25–$1121.48) $57.80 ($29.37–$108.68)
92558 only 66 (0.1) $63.86 ($8.40–$293.61) $60.35 ($21.92–$95.85)
92587 only 2,162 (3.0) $73.67 ($2.25–$1121.48) $57.14 ($29.65–$109.24)
92586 Automated ABR 69,948 (96.9) $162.20 ($1.04–$1580.10) $150.00 ($104.40–$210.68)
Outpatient Newborn Hearing Screen (n = 1,300 claims)
CPT Codes n (%) Mean (Range) Median (IQR)
Office
92558 or 92587 255 (19.6) $45.42 ($4.11–$360.00) $39.74 ($27.63–$52.54)
92586 249 (19.2) $136.33 ($31.71–$714.00) $102.18 ($75.81–$169.13)
Outpatient Hospital
92558 or 92587 750 (57.7) $155.98 ($2.03–$1320.78) $116.90 ($78.22–$178.27)
92586 46 (3.5) $184.09 ($2.43–$650.00) $164.34 ($94.02–$254.00)
Irrespective of outpatient place of service
92558 39 (3.0) $41.98 ($6.85–$176.27) $33.00 ($12.78–$60.00)
92587 966 (74.3) $74.75 ($2.03–$1320.78) $47.64 ($30.74–$83.98)
92586 295 (22.7) $176.65 ($2.43–$714.00) $156.90 ($87.23–$250.00)
Note. CPT = Current Procedural Terminology; IQR = Interquartile Range. 
*IBM® MarketScan® Commercial Databases for 2013–2015
As shown in Tables 4 and 5, the average reimbursement 
rates varied by census division. For inpatient hearing 
screens, the South Atlantic had the highest median 
reimbursement rate and East South Central had the 
lowest median reimbursement rate ($196.02, IQR 
$98.74–$239.14 and $107.93, IQR $85.22–$160.00, 
respectively; Table 4). For outpatient hearing screens, the 
lowest median reimbursement rates ranged from $32.02 
(IQR $24.00–$58.28) in the West South Central to the 
highest $158.56 (IQR $57.52–$210.00) in the Pacific 
(Table 5). The census division with the highest median 
reimbursement for an outpatient service in a hospital 
facility and office visit were Middle Atlantic ($195.57, IQR 
$105.20–$254.00) and Pacific ($49.25, IQR $31.71–
$57.52; Table 5).
Discussion
Our estimates of average reimbursement for NBHS by 
private insurers for screening conducted in birth hospitals 
are substantially greater than published estimates of the 
resource costs of providing such services. Published 
U.S. cost estimates for pre-discharge hospital screening 
have generally been in the range of $27 to $47 per infant 
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screened, adjusted for inflation to 2016 U.S. dollars 
(Grosse et al., 2018). In contrast, average inpatient NBHS 
reimbursements reported here, with IQR from $100 to 
$210 (Table 2), are several times as high. 
Our retrospective analysis of the private insurance 
reimbursements rate for NBHS services using IBM® 
MarketScan® Commercial Research Databases 
(2013–2015) complements previous analyses (Grosse, 
2006; McManus et al., 2010). There are a limited 
number of NBHS cost studies specifically looking at 
the reimbursement rate using the procedure codes. 
Whereas McManus et al. (2010) investigated the Medicaid 
reimbursement rates for all types of hearing services 
for infants and young children, our study provides 
reimbursement estimates by setting and type of screening 
services for privately insured infants. McManus et al. 
(2010) reported mean Medicaid reimbursement rates of 
$106.30 for automated ABR (CPT 92586) and $99.40 
for OAE with limited evaluation (CPT 92587 adjusted 
for inflation to 2014 dollars) irrespective of inpatient or 
outpatient setting. Our mean estimates for automated ABR 
(CPT 92586: $162.26, range $1.04–$1580.10) and OAE 
with limited evaluation (CPT 92587: $74.00, range $2.03–
$1320.78) irrespective of inpatient or outpatient setting 
Table 4
Summary of Inpatient Net Payment Reimbursement by Census Division*
Census Division
Inpatient Newborn Hearing Screening (n = 72,146 claims)
No. of 
Claims Mean (Range) Median (IQR)
New England 1,208 $175.11 ($2.57–$980.70) $120.17 ($109.09–$215.10) 
Middle Atlantic 6,493 $177.17 ($2.52–$1106.50) $144.00 ($109.60–$239.00) 
East North Central 6,680 $127.27 ($1.63–$840.00) $116.00 ($104.21–$139.82)
West North Central 2,377 $117.54 ($2.80–$714.00) $113.51 ($90.00–$135.00)
South Atlantic 9,735 $178.18 ($1.23–$1121.48) $196.02 ($98.74–$239.14)
East South Central 5,718 $123.99 ($1.41–$490.04) $107.93 ($85.22–$160.00)
West South Central 19,273 $185.79 ($1.15–$1580.10) $185.00 ($148.00–$246.46)
Mountain 12,506 $139.02 ($1.32–$478.00) $136.18 ($90.19–$179.25)
Pacific 7,505 $152.90 ($1.04–$576.78) $143.40 ($81.42–$215.00)
Unknown Region 681 $157.17 ($5.31–$714.00) $148.00 ($104.49–$204.30)
Note. IQR = Interquartile Range.
* IBM® MarketScan® Commercial Databases for 2013–2015
Table 5
Summary of Outpatient Net Payment Reimbursement by Census Division*
Census Division
Newborn Hearing Screening Outpatient (n = 1,300 claims)
All Outpatient Claims Outpatient by Place of Service
No. of 
Claims
Outpatient Mean 
(Range)
Outpatient Median 
(IQR)
Outpatient Hospital 
Median (IQR)
Office Median 
(IQR)
New England 25 $99.04 ($21.59–$482.11) $66.40 ($40.23–$145.09) $151.18 ($69.27–$164.21) $40.23 ($40.23–$60.56)
Middle Atlantic 289 $100.92 ($2.43–$734.25) $54.92 ($39.50–$121.50) $195.57 ($105.20–$254.00) $45.18 ($34.00–$54.92)
East North Central 95 $96.56 ($17.99–$1320.78) $57.60 ($42.88–$93.33) $102.66 ($81.48–$182.47) $44.80 ($32.42–$57.60)
West North Central 26 $65.51 ($12.78–$176.27) $47.37 ($39.65–$91.50) $82.35 ($39.65–$105.00) $45.00 ($21.00–$78.00)
South Atlantic 227 $113.32 ($4.11–$714.00) $69.59 ($37.75–$140.18) $169.06 ($93.25–$293.78) $47.59 ($32.36–$81.23)
East South Central 92 $88.45 ($4.69–$640.80) $51.82 ($33.90–$97.87) $128.21 ($98.09–$287.66) $38.57 ($33.90–$55.90)
West South Central 230 $62.04 ($4.43–$1122.66) $32.02 ($24.00–$58.28) $103.41 ($60.91–$182.59) $30.48 ($21.34–$43.59)
Mountain 181 $78.67 ($2.03–$339.08) $72.56 ($41.92–$106.77) $94.02 ($72.56–$131.08) $41.97 ($24.97–$61.10)
Pacific 126 $78.67 ($22.71–$550.00) $158.56 ($57.52–$210.00) $175.00 ($138.53–$281.86) $49.25 ($31.71–$57.52)
Note. CPT = Current Procedural Terminology; IQR = Interquartile Range. Results for unknown region (n = 9) are not 
shown because of small numbers.
*IBM® MarketScan® Commercial Databases for 2013-2015
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were higher for privately insured infants than for infants 
with Medicaid (results not shown).
It should be emphasized that the vast majority (84.3%) of 
privately insured infants who received a hospital-based 
NBHS were not separately billed for the service because 
the cost of providing a hearing screen for a newborn is 
typically bundled under the newborn delivery care charge. 
Consequently, the reimbursements reported here do 
not characterize how much hospitals are reimbursed for 
NBHS. The reimbursement rate reported here in most, 
if not all, cases reflect reimbursements to independent 
providers or contractors contracted to perform NBHS. 
We were unable to find studies on the estimated resource 
cost of conducting screening by an independent provider 
or contractor contracted to perform NBHS. In contrast, we 
found several older studies that have reported resource 
cost estimates associated with NBHS conducted by 
hospital staff (Kezirian, White, Yueh, & Sullivan, 2001; 
Maxon, White, Behrens, & Vohr, 1995; Mehl & Thomson, 
1998; Vohr et al., 2001). Kezirian et al. and Vohr et al. 
estimates were based on direct cost of the equipment, 
overhead, and all personnel cost including clerical 
administrative assistance cost. Kezirian et al. reported 
the cost of providing an OAE hearing screen was $13 per 
infant and the cost for an automated ABR hearing screen 
was $25 per infant. Vohr et al. reported $28.69 for an OAE 
hearing screen and $32.81 for an automated ABR hearing 
screen. Adjusting to 2014 dollars, the cost of providing an 
OAE hearing screen would range from $17.38 to $38.25 
and the cost of an automated ABR screen would range 
from $33.42 to $43.86. These costs would not accurately 
describe the cost for independent providers or contractors 
contracted to perform NBHS. Since those cost estimates 
are very old, it is not clear that adjustment for inflation is 
sufficient. It would be helpful to have estimates from new 
hearing screening cost studies. 
Reimbursement rates appeared to be dependent on 
the type of hearing screening service and place of 
service. Unlike previous studies that reported only mean 
reimbursements, this analysis provided means, medians, 
range, and IQRs for reimbursements. The median, unlike 
the mean, is not influenced by a small number of extremely 
large or small values. Therefore, the median net payment 
may provide a better estimate of the typical inpatient 
reimbursement. 
This study provides new cost information on how the two 
screening methods were used across places of service, 
OAE, and automated ABR. Almost half (49.4%) of privately 
insured infants who were individually billed for NBHS as 
an inpatient received an automated ABR screen, while 
almost all (94.2%) infants who were individually billed for 
outpatient NBHS received an OAE screen (Table 3). The 
decision to use ABR screening equipment by a hospital for 
inpatient screening could be driven by both best practice 
considerations and the higher reimbursement rate relative 
to OAE hearing screen. On average, the claim for an 
automated ABR screen performed as an inpatient service 
(median payment) was reimbursed 2.6 times higher than 
for an OAE hearing screen performed in the same setting. 
The ratio of reimbursements between the two types of 
service was also the same for office visit claims, yet  only 
half of inpatient visit claims were for OAE. 
We found the median net payment per claim for NBHS 
was almost three times as high for inpatient as for 
outpatient claims (Table 2). This appears to largely reflect 
differences in the relative shares of automated ABR 
and OAE screening types between inpatient and office 
visits. Within those settings there were much smaller 
differences in reimbursements by service type. In hospital 
outpatient claims, reimbursements were similarly high 
for both service types (Table 3). Separately reporting 
outpatient and inpatient reimbursements provides a more 
comprehensive and accurate summary of the variability in 
reimbursement rates by type of service. 
The higher average reimbursement for automated ABR 
than OAE hearing screening services performed as an 
inpatient service in the hospital is consistent with some 
published estimates of resource costs (Kezirian et al., 
2001; Lin et al., 2005; Lin, Shu, Lee, Lin, & Lin, 2007). 
Performing automated ABR requires the use of disposable 
electrodes, which is not required for an OAE hearing 
screening procedure. The electrode supply adds to the 
total cost of providing an automated ABR hearing screen. 
However, a few studies reported little cost difference 
between automated ABR and OAE hearing screening 
services (Lemons et al., 2002; Vohr et al., 2001).
The median and mean reimbursements for an automated 
ABR screen performed for an outpatient hospital service, 
$164.34 and $184.09, were higher than the reimbursement 
rate in an office setting, $102.18 and $136.33, but similar 
to the inpatient hospital reimbursement rate of $150.00 
and $162.20. For OAE hearing screens, the median and 
mean reimbursements were lower when conducted in 
an office setting, $39.74 and $45.42, than in an inpatient 
setting, $57.80 and $73.38. The highest reimbursement 
rate for OAE screening service took place in a hospital 
setting as an outpatient service, $116.90 and $155.98. In 
the inpatient and outpatient settings, reimbursements were 
lower for OAE than automated ABR hearing screen.
We were unable to find any previously published cost 
study specifically looking at the cost of providing hearing 
screening in an office as the place of service after infants 
have been discharged from the hospital. We were able 
to find the cost for providing post-discharge hearing 
screens in five hospitals in one study (Vohr et al., 2001). 
Vohr et al. reported the cost for providing an OAE screen 
as $66.87. According to our analysis, an outpatient OAE 
screen performed in a hospital setting was reimbursed 
at a median rate of $116.90 and a mean of $155.98 
for privately insured infants. The cost for providing an 
ABR screen was reported as $95.04 (adjusted to 2014 
dollars) by Vohr et al. and we found the median and mean 
reimbursement rates for an automated ABR screen (CPT 
92856) were $102.18 and $136.33 respectively.
This analysis has several limitations. First, billing codes 
are subject to coding errors (O’Malley et al., 2005), which 
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means that some claims for what appear to be NBHS may 
actually be for a different service. Second, we examined 
claims data from 2013 to 2015 for the 2013–2014 
birth cohort using ICD-9-CM codes to avoid the coding 
transition to ICD-10 on October 1, 2015. However, the 
claims data are now more than 4 years old and may be 
a bit dated. The estimates may have changed since the 
study was completed in 2017. Finally, the data used in 
this study comes from employer-based plans and cannot 
be generalized to other types of private payers. The 
MarketScan Commercial data have been found to be 
comparable in demographics to the U.S. population with 
employer-sponsored insurance (Aizcorbe et al., 2012), 
which in turn comprises more than 90% of the U.S. 
population with private insurance. However, MarketScan 
data cannot be generalized to populations with public 
insurance or no insurance. 
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